Dyslipidemias: Pathophysiology, evaluation and management

Research output: Book/ReportBook

5 Citations (Scopus)

Abstract

Dyslipidemias: Pathophysiology, Evaluation and Managementprovides a wealth of general and detailed guidelines for the clinical evaluation and management of lipid disorders in adults and children. Covering the full range of common through rare lipid disorders, this timely resource offers targeted, practical information for all clinicians who care for patients with dyslipidemias, including general internists, pediatric and adult endocrinologists, pediatricians, lipidologists, cardiologists, internists, and geneticists. For the last twenty years, there has been a growing recognition worldwide of the importance of managing dyslipidemia for the primary and secondary prevention of atherosclerotic vascular disease, especially coronary heart disease. This has been mainly due to the publication of the guidelines of National Cholesterol Education Program’s Adult Treatment Panel and Pediatric Panel from the United States. These guidelines have stimulated generation of similar recommendations from all over the world, particularly Europe, Canada, Australia and Asia. Developed by a renowned group of leading international experts, the book offers state-of-the-art chapters that are peer-reviewed and represent a comprehensive assessment of the field. A major addition to the literature, Dyslipidemias: Pathophysiology, Evaluation and Management is a gold-standard level reference for all clinicians who are challenged to provide the best care and new opportunities for patients with dyslipidemias.

Original languageEnglish (US)
PublisherHumana Press Inc.
Number of pages525
ISBN (Print)9781607614241, 9781607614234
DOIs
StatePublished - Jan 1 2015

Fingerprint

Dyslipidemias
Guidelines
Pediatrics
Lipids
Primary Prevention
Secondary Prevention
Vascular Diseases
Gold
Canada
Coronary Disease
Publications
Patient Care
Cholesterol
Education
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Dyslipidemias : Pathophysiology, evaluation and management. / Garg, Abhimanyu.

Humana Press Inc., 2015. 525 p.

Research output: Book/ReportBook

@book{176190289b8e4bfb860cbbbc82dbbdfc,
title = "Dyslipidemias: Pathophysiology, evaluation and management",
abstract = "Dyslipidemias: Pathophysiology, Evaluation and Managementprovides a wealth of general and detailed guidelines for the clinical evaluation and management of lipid disorders in adults and children. Covering the full range of common through rare lipid disorders, this timely resource offers targeted, practical information for all clinicians who care for patients with dyslipidemias, including general internists, pediatric and adult endocrinologists, pediatricians, lipidologists, cardiologists, internists, and geneticists. For the last twenty years, there has been a growing recognition worldwide of the importance of managing dyslipidemia for the primary and secondary prevention of atherosclerotic vascular disease, especially coronary heart disease. This has been mainly due to the publication of the guidelines of National Cholesterol Education Program’s Adult Treatment Panel and Pediatric Panel from the United States. These guidelines have stimulated generation of similar recommendations from all over the world, particularly Europe, Canada, Australia and Asia. Developed by a renowned group of leading international experts, the book offers state-of-the-art chapters that are peer-reviewed and represent a comprehensive assessment of the field. A major addition to the literature, Dyslipidemias: Pathophysiology, Evaluation and Management is a gold-standard level reference for all clinicians who are challenged to provide the best care and new opportunities for patients with dyslipidemias.",
author = "Abhimanyu Garg",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-1-60761-424-1",
language = "English (US)",
isbn = "9781607614241",
publisher = "Humana Press Inc.",

}

TY - BOOK

T1 - Dyslipidemias

T2 - Pathophysiology, evaluation and management

AU - Garg, Abhimanyu

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Dyslipidemias: Pathophysiology, Evaluation and Managementprovides a wealth of general and detailed guidelines for the clinical evaluation and management of lipid disorders in adults and children. Covering the full range of common through rare lipid disorders, this timely resource offers targeted, practical information for all clinicians who care for patients with dyslipidemias, including general internists, pediatric and adult endocrinologists, pediatricians, lipidologists, cardiologists, internists, and geneticists. For the last twenty years, there has been a growing recognition worldwide of the importance of managing dyslipidemia for the primary and secondary prevention of atherosclerotic vascular disease, especially coronary heart disease. This has been mainly due to the publication of the guidelines of National Cholesterol Education Program’s Adult Treatment Panel and Pediatric Panel from the United States. These guidelines have stimulated generation of similar recommendations from all over the world, particularly Europe, Canada, Australia and Asia. Developed by a renowned group of leading international experts, the book offers state-of-the-art chapters that are peer-reviewed and represent a comprehensive assessment of the field. A major addition to the literature, Dyslipidemias: Pathophysiology, Evaluation and Management is a gold-standard level reference for all clinicians who are challenged to provide the best care and new opportunities for patients with dyslipidemias.

AB - Dyslipidemias: Pathophysiology, Evaluation and Managementprovides a wealth of general and detailed guidelines for the clinical evaluation and management of lipid disorders in adults and children. Covering the full range of common through rare lipid disorders, this timely resource offers targeted, practical information for all clinicians who care for patients with dyslipidemias, including general internists, pediatric and adult endocrinologists, pediatricians, lipidologists, cardiologists, internists, and geneticists. For the last twenty years, there has been a growing recognition worldwide of the importance of managing dyslipidemia for the primary and secondary prevention of atherosclerotic vascular disease, especially coronary heart disease. This has been mainly due to the publication of the guidelines of National Cholesterol Education Program’s Adult Treatment Panel and Pediatric Panel from the United States. These guidelines have stimulated generation of similar recommendations from all over the world, particularly Europe, Canada, Australia and Asia. Developed by a renowned group of leading international experts, the book offers state-of-the-art chapters that are peer-reviewed and represent a comprehensive assessment of the field. A major addition to the literature, Dyslipidemias: Pathophysiology, Evaluation and Management is a gold-standard level reference for all clinicians who are challenged to provide the best care and new opportunities for patients with dyslipidemias.

UR - http://www.scopus.com/inward/record.url?scp=84956809266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956809266&partnerID=8YFLogxK

U2 - 10.1007/978-1-60761-424-1

DO - 10.1007/978-1-60761-424-1

M3 - Book

AN - SCOPUS:84956809266

SN - 9781607614241

SN - 9781607614234

BT - Dyslipidemias

PB - Humana Press Inc.

ER -